+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Transfusion Devices Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010985
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood Transfusion Devices Market is projected to reach USD 5.10 Billion in 2026. It is expected to continue growing at a CAGR of 7.63%, reaching USD 7.93 Billion by 2032.

Blood Transfusion Devices: Executive Overview

Blood transfusion devices support the collection, processing, storage, monitoring, and administration of blood and blood components. The field includes collection systems, blood bags, mixers, warmers, infusion and transfusion pumps, filters, separators, and related safety technologies. Demand is shaped by transfusion-dependent care, surgical activity, trauma response, oncology, obstetrics, chronic disease management, and the need to improve compatibility and infection-control practices.

Safety, Automation, and Workflow Integration Are Reshaping Transfusion Care

The landscape is shifting toward safer, more standardized, and more traceable workflows. Blood establishments and hospitals are emphasizing closed-system processing, leukoreduction, component separation, temperature control, bedside identification, and documentation that connects laboratory and clinical records. Automation is also reducing manual handling in collection and processing, while interoperability is becoming more important as providers seek fewer transcription errors and clearer chain-of-custody visibility. Regulatory compliance, staff training, equipment validation, and dependable maintenance remain central to adoption.

Artificial Intelligence Strengthens Screening, Traceability, and Operational Decisions

Artificial intelligence can contribute to transfusion-device workflows through image-assisted inspection, anomaly detection, demand and inventory planning, maintenance alerts, and decision support for blood-component selection. It may also help identify discrepancies across patient, sample, product, and administration records when deployed within validated information systems. However, safe use requires representative data, transparent validation, cybersecurity controls, human oversight, and clear accountability. AI is therefore most useful as an augmentation layer around established laboratory, clinical, and quality-management processes rather than as an unsupported replacement for professional judgment.

Regional Insights: Uneven Infrastructure Creates Distinct Adoption Priorities

North America generally emphasizes automation, interoperability, traceability, and regulatory compliance across mature hospital and blood-center networks. Europe focuses on harmonized quality requirements, patient blood management, component safety, and cross-border consistency, while national procurement and reimbursement structures still influence implementation. Asia-Pacific combines advanced systems in developed healthcare markets with substantial capacity-building needs elsewhere, making affordability, reliability, and scalable infrastructure important. Latin America continues to prioritize dependable collection, storage, screening, and distribution capabilities alongside workforce development. The Middle East is strengthening centralized and hospital-based services, with emphasis on quality assurance and emergency readiness. Africa faces pronounced variation in supply-chain resilience, laboratory capacity, equipment servicing, and access to safe transfusion, increasing the value of robust, maintainable technologies and public-health partnerships.

Group Insights: Economic and Institutional Blocs Shape Standards and Access

ASEAN members present varied regulatory environments and healthcare capacities, creating opportunities for interoperable systems, regional training, and adaptable equipment configurations. BRICS countries span large and diverse blood systems, where domestic manufacturing, decentralized service delivery, and access to dependable consumables are recurring priorities. The European Union places strong weight on common safety principles, data governance, traceability, and coordinated quality practices, although implementation remains nationally organized. G7 members typically prioritize advanced automation, patient blood management, cybersecurity, and evidence-based procurement. GCC countries continue developing highly equipped healthcare networks and centralized capabilities, with workforce localization and emergency preparedness as important considerations. NATO members have an additional interest in resilient medical logistics, continuity of supply, and transfusion readiness during disasters or high-demand events.

Country Insights: National Systems Determine Device Priorities

Australia emphasizes geographically resilient supply, quality assurance, and integration across dispersed services. Brazil must address regional disparities while strengthening collection, processing, and distribution capacity. Canada values interoperability, safety, and dependable service across large distances. China combines extensive healthcare demand with investment in domestic capability, automation, and standardized processing. France, Germany, Italy, and Spain operate within a strong European quality context while retaining distinct procurement and service structures. India’s priorities include scalable infrastructure, affordability, reliable cold-chain management, and broader access across urban and rural settings. Japan and South Korea emphasize precision, automation, traceability, and technologically advanced hospital workflows. Mexico continues to balance modernization with uneven institutional capacity. Russia places importance on domestic resilience, centralized coordination, and dependable supply. The United Kingdom focuses on hemovigilance, patient blood management, interoperability, and system-wide efficiency. The United States emphasizes regulatory compliance, automation, data integration, and preparedness across complex public and private networks.

Leadership Priorities for Safer, More Resilient Transfusion Operations

Industry leaders should first map the complete transfusion pathway, identifying points where misidentification, temperature excursions, contamination, delays, or documentation gaps can occur. Procurement should evaluate total lifecycle performance, including consumable compatibility, validation requirements, cybersecurity, training, calibration, service coverage, and end-of-life handling. Organizations should prioritize interoperable identification and data exchange, while preserving human verification at critical control points. Investment decisions should be linked to patient blood management, measurable quality indicators, and local workforce capability. Leaders should also establish contingency plans for shortages, disasters, power interruptions, and logistics disruptions, and introduce AI only through controlled pilots with documented validation, monitoring, and clinical governance.

Methodology: Evidence-Based Synthesis of Transfusion-Device Dynamics

This executive summary uses the defined blood transfusion devices market scope and organizes findings around device functions, care pathways, safety requirements, technology adoption, infrastructure conditions, and healthcare-system priorities. The analysis distinguishes broadly observed industry dynamics from geography-specific considerations and avoids unsupported numerical claims. Regional, group, and country perspectives are synthesized from the stated coverage framework and established characteristics of transfusion services, including regulation, infrastructure, logistics, workforce, interoperability, and emergency preparedness. Conclusions are qualitative and intended to support strategic interpretation rather than quantify market performance.

Conclusion: Safety and System Resilience Will Define Progress

Blood transfusion devices are becoming increasingly connected to broader goals for patient safety, laboratory quality, operational efficiency, and emergency readiness. Progress will depend less on isolated equipment upgrades than on coordinated improvement across identification, processing, storage, administration, information systems, workforce capability, and maintenance. Regional and national conditions require adaptable approaches, while AI and automation should be introduced with rigorous validation and human oversight. Leaders that combine reliable technology with resilient operating models will be better positioned to improve transfusion quality and continuity of care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Transfusion Devices Market, by Product
7.1. Introduction
7.2. Apheresis System
7.2.1. Double Needle
7.2.2. Single Needle
7.3. Blood Bag
7.3.1. Multi Pocket
7.3.2. Single Pocket
7.4. Blood Collection Set
7.4.1. Closed System
7.4.2. Open System
7.5. Component Separator
7.5.1. Automated Separator
7.5.2. Manual Separator
7.6. Leukocyte Reduction Filter
7.6.1. Bedside
7.6.2. Pre Storage
7.7. Transfusion Pump
7.7.1. Syringe
7.7.2. Volumetric
8. Blood Transfusion Devices Market, by Component
8.1. Introduction
8.2. Plasma
8.2.1. Cryoprecipitate
8.2.2. Fresh Frozen Plasma
8.3. Platelets
8.3.1. Apheresis Platelets
8.3.2. Pooled Platelets
8.4. Red Blood Cells
8.5. White Blood Cells
8.5.1. Granulocyte Concentrates
8.5.2. Lymphocyte Concentrates
9. Blood Transfusion Devices Market, by Mode
9.1. Introduction
9.2. Automated
9.2.1. Fully Automated Desktop
9.2.2. Robotic Systems
9.3. Manual
9.4. Semi Automated
9.4.1. Cartridge Based
9.4.2. Cassette Based
10. Blood Transfusion Devices Market, by Technology
10.1. Introduction
10.2. Conventional Flow Control
10.2.1. Gravity Fed
10.2.2. Pressure Infusion
10.3. Electronic Flow Control
10.3.1. Microprocessor Based
10.3.2. Sensor Based
11. Blood Transfusion Devices Market, by Application
11.1. Introduction
11.2. Apheresis
11.2.1. Collection Apheresis
11.2.2. Therapeutic Apheresis
11.3. Blood Collection
11.3.1. Apheresis Collection
11.3.2. Whole Blood Collection
11.4. Component Separation
11.4.1. Centrifugation Based
11.4.2. Filtration Based
11.5. Leukocyte Reduction
11.5.1. Centrifugation Based
11.5.2. Filtration Based
11.6. Transfusion
11.6.1. Continuous Transfusion
11.6.2. Intermittent Transfusion
12. Blood Transfusion Devices Market, by End User
12.1. Introduction
12.2. Blood Banks & Donation Centers
12.2.1. Government Centers
12.2.2. Private Centers
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
13. Blood Transfusion Devices Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Hospital Pharmacies
13.3.1. Centralized
13.3.2. In House
13.4. Online Sales
13.4.1. B2B Platforms
13.4.2. Manufacturer Websites
13.5. Retail Pharmacies
14. Blood Transfusion Devices Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Blood Transfusion Devices Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Blood Transfusion Devices Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. B. Braun Melsungen AG
18.2. Baxter International Inc.
18.3. Becton, Dickinson and Company
18.4. bioMérieux SA
18.5. Cerus Corporation
18.6. Fresenius Kabi AG
18.7. Grifols, S.A.
18.8. Haemonetics Corporation
18.9. Immucor, Inc.
18.10. Jiangsu Kangjin Medical Instrument Co.,Ltd.
18.11. Macopharma SA
18.12. Nipro Medical Corporation
18.13. Sarstedt AG & Co. KG
18.14. Siemens AG
18.15. SURU INTERNATIONAL PVT. LTD.
18.16. Terumo Corporation
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Blood Transfusion Devices Market, Years Considered for the Study
FIGURE 2. Global Blood Transfusion Devices Market, Research Design
FIGURE 3. Global Blood Transfusion Devices Market, Research Framework
FIGURE 4. Global Blood Transfusion Devices Market, Data Triangulation
FIGURE 5. Global Blood Transfusion Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Blood Transfusion Devices Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Blood Transfusion Devices Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Blood Transfusion Devices Market Size, by Component, 2025 vs 2032 (%)
FIGURE 9. Global Blood Transfusion Devices Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Blood Transfusion Devices Market Size, by Mode, 2025 vs 2032 (%)
FIGURE 11. Global Blood Transfusion Devices Market Size, by Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Blood Transfusion Devices Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 13. Global Blood Transfusion Devices Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Blood Transfusion Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Blood Transfusion Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Blood Transfusion Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Blood Transfusion Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Blood Transfusion Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 19. Global Blood Transfusion Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Blood Transfusion Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Blood Transfusion Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Blood Transfusion Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Blood Transfusion Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Blood Transfusion Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Blood Transfusion Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Blood Transfusion Devices Market Segmentation & Coverage
TABLE 2. Global Blood Transfusion Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Blood Transfusion Devices Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Apheresis System Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Apheresis System Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Apheresis System Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Double Needle Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Double Needle Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Double Needle Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Single Needle Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Single Needle Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Single Needle Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Blood Bag Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Blood Bag Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Blood Bag Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Multi Pocket Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Multi Pocket Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Multi Pocket Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Single Pocket Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Single Pocket Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Single Pocket Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Blood Collection Set Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Blood Collection Set Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Blood Collection Set Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Closed System Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Closed System Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Closed System Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Open System Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Open System Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Open System Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Component Separator Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Component Separator Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Component Separator Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Automated Separator Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Automated Separator Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Automated Separator Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Manual Separator Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Manual Separator Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Manual Separator Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Leukocyte Reduction Filter Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Leukocyte Reduction Filter Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Leukocyte Reduction Filter Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Bedside Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Bedside Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Bedside Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Pre Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Pre Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Pre Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Transfusion Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Transfusion Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Transfusion Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Volumetric Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Volumetric Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Volumetric Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Blood Transfusion Devices Market Size, by Component, 2017-2032 (USD Million)
TABLE 59. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Cryoprecipitate Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Cryoprecipitate Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Cryoprecipitate Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Fresh Frozen Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Fresh Frozen Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Fresh Frozen Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Platelets Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Platelets Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Platelets Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Apheresis Platelets Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Apheresis Platelets Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Apheresis Platelets Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Pooled Platelets Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Pooled Platelets Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Pooled Platelets Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Red Blood Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Red Blood Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Red Blood Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global White Blood Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global White Blood Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global White Blood Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Granulocyte Concentrates Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Granulocyte Concentrates Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Granulocyte Concentrates Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Lymphocyte Concentrates Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Lymphocyte Concentrates Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Lymphocyte Concentrates Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Blood Transfusion Devices Market Size, by Mode, 2017-2032 (USD Million)
TABLE 90. Global Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Fully Automated Desktop Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Fully Automated Desktop Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Fully Automated Desktop Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Robotic Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Robotic Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Robotic Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Manual Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Manual Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Manual Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Semi Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Semi Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Semi Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Cartridge Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Cartridge Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Cartridge Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Cassette Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Cassette Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Cassette Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Blood Transfusion Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 112. Global Conventional Flow Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Conventional Flow Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Conventional Flow Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Gravity Fed Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Gravity Fed Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Gravity Fed Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Pressure Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Pressure Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Pressure Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Electronic Flow Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Electronic Flow Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Electronic Flow Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Microprocessor Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Microprocessor Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Microprocessor Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Sensor Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Sensor Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Sensor Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Blood Transfusion Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Global Apheresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Apheresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Apheresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Collection Apheresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Collection Apheresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Collection Apheresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Therapeutic Apheresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Therapeutic Apheresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Therapeutic Apheresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Blood Collection Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Blood Collection Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Blood Collection Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Apheresis Collection Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Apheresis Collection Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Apheresis Collection Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Whole Blood Collection Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Whole Blood Collection Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Whole Blood Collection Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Component Separation Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Component Separation Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Component Separation Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Centrifugation Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Centrifugation Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Centrifugation Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Filtration Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Filtration Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Filtration Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Leukocyte Reduction Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Leukocyte Reduction Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Leukocyte Reduction Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Centrifugation Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Centrifugation Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Centrifugation Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Filtration Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Filtration Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Filtration Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Transfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Transfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Transfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Continuous Transfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Continuous Transfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Continuous Transfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Intermittent Transfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Intermittent Transfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Intermittent Transfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Blood Transfusion Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Global Blood Banks & Donation Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Blood Banks & Donation Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Blood Banks & Donation Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Government Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Government Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Government Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Private Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Private Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Private Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Blood Transfusion Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Centralized Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Centralized Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Centralized Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global In House Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Global In House Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. Global In House Market Size, by Country, 2017-2032 (USD Million)
TABLE 208. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 211. Global B2B Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Global B2B Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. Global B2B Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 214. Global Manufacturer Websites Market Size, by Region, 2017-2032 (USD Million)
TABLE 215. Global Manufacturer Websites Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. Global Manufacturer Websites Market Size, by Country, 2017-2032 (USD Million)
TABLE 217. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 220. Global Blood Transfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific Blood Transfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific Blood Transfusion Devices Market Size, by Product, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific Blood Transfusion Devices Market Size, by Apheresis System, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific Blood Transfusion Devices Market Size, by Blood Bag, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific Blood Transfusion Devices Market Size, by Blood Collection Set, 2017-2032 (USD Million)
TABLE 226. Asia-Pacific Blood Transfusion Devices Market Size, by Component Separator, 2017-2032 (USD Million)
TABLE 227. Asia-Pacific Blood Transfusion Devices Market Size, by Leukocyte Reduction Filter, 2017-2032 (USD Million)
TABLE 228. Asia-Pacific Blood Transfusion Devices Market Size, by Transfusion Pump, 2017-2032 (USD Million)
TABLE 229. Asia-Pacific Blood Transfusion Devices Market Size, by Component, 2017-2032 (USD Million)
TABLE 230. Asia-Pacific Blood Transfusion Devices Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 231. Asia-Pacific Blood Transfusion Devices Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 232. Asia-Pacific Blood Transfusion Devices Market Size, by White Blood Cells, 2017-2032 (USD Million)
TABLE 233. Asia-Pacific Blood Transfusion Devices Market Size, by Mode, 2017-2032 (USD Million)
TABLE 234. Asia-Pacific Blood Transfusion Devices Market Size, by Automated, 2017-2032 (USD Million)
TABLE 235. Asia-Pacific Blood Transfusion Devices Market Size, by Semi Automated, 2017-2032 (USD Million)
TABLE 236. Asia-Pacific Blood Transfusion Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Asia-Pacific Blood Transfusion Devices Market Size, by Conventional Flow Control, 2017-2032 (USD Million)
TABLE 238. Asia-Pacific Blood Transfusion Devices Market Size, by Electronic Flow Control, 2017-2032 (USD Million)
TABLE 239. Asia-Pacific Blood Transfusion Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Asia-Pacific Blood Transfusion Devices Market Size, by Apheresis, 2017-2032 (USD Million)
TABLE 241. Asia-Pacific Blood Transfusion Devices Market Size, by Blood Collection, 2017-2032 (USD Million)
TABLE 242. Asia-Pacific Blood Transfusion Devices Market Size, by Component Separation, 2017-2032 (USD Million)
TABLE 243. Asia-Pacific Blood Transfusion Devices Market Size, by Leukocyte Reduction, 2017-2032 (USD Million)
TABLE 244. Asia-Pacific Blood Transfusion Devices Market Size, by Transfusion, 2017-2032 (USD Million)
TABLE 245. Asia-Pacific Blood Transfusion Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Asia-Pacific Blood Transfusion Devices Market Size, by Blood Banks & Donation Centers, 2017-2032 (USD Million)
TABLE 247. Asia-Pacific Blood Transfusion Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. Asia-Pacific Blood Transfusion Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. Asia-Pacific Blood Transfusion Devices Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 250. Asia-Pacific Blood Transfusion Devices Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 251. North America Blood Transfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. North America Blood Transfusion Devices Market Size, by Product, 2017-2032 (USD Million)
TABLE 253. North America Blood Transfusion Devices Market Size, by Apheresis System, 2017-2032 (USD Million)
TABLE 254. North America Blood Transfusion Devices Market Size, by Blood Bag, 2017-2032 (USD Million)
TABLE 255. North America Blood Transfusion Devices Market Size, by Blood Collection Set, 2017-2032 (USD Million)
TABLE 256. North America Blood Transfusion Devices Market Size, by Component Separator, 2017-2032 (USD Million)
TABLE 257. North America Blood Transfusion Devices Market Size, by Leukocyte Reduction Filter, 2017-2032 (USD Million)
TABLE 258. North America Blood Transfusion Devices Market Size, by Transfusion Pump, 2017-2032 (USD Million)
TABLE 259. North America Blood Transfusion Devices Market Size, by Component, 2017-2032 (USD Million)
TABLE 260. North America Blood Transfusion Devices Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 261. North America Blood Transfusion Devices Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 262. North America Blood Transfusion Devices Market Size, by White Blood Cells, 2017-2032 (USD Million)
TABLE 263. North America Blood Transfusion Devices Market Size, by Mode, 2017-2032 (USD Million)
TABLE 264. North America Blood Transfusion Devices Market Size, by Automated, 2017-2032 (USD Million)
TABLE 265. North America Blood Transfusion Devices Market Size, by Semi Automated, 2017-2032 (USD Million)
TABLE 266. North America Blood Transfusion Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. North America Blood Transfusion Devices Market Size, by Conventional Flow Control, 2017-2032 (USD Million)
TABLE 268. North America Blood Transfusion Devices Market Size, by Electronic Flow Control, 2017-2032 (USD Million)
TABLE 269. North America Blood Transfusion Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. North America Blood Transfusion Devices Market Size, by Apheresis, 2017-2032 (USD Million)
TABLE 271. North America Blood Transfusion Devices Market Size, by Blood Collection, 2017-2032 (USD Million)
TABLE 272. North America Blood Transfusion Devices Market Size, by Component Separation, 2017-2032 (USD Million)
TABLE 273. North America Blood Transfusion Devices Market Size, by Leukocyte Reduction, 2017-2032 (USD Million)
TABLE 274. North America Blood Transfusion Devices Market Size, by Transfusion, 2017-2032 (USD Million)
TABLE 275. North America Blood Transfusion Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. North America Blood Transfusion Devices Market Size, by Blood Banks & Donation Centers, 2017-2032 (USD Million)
TABLE 277. North America Blood Transfusion Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 278. North America Blood Transfusion Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. North America Blood Transfusion Devices Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 280. North America Blood Transfusion Devices Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 281. Latin America Blood Transfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 282. Latin America Blood Transfusion Devices Market Size, by Product, 2017-2032 (USD Million)
TABLE 283. Latin America Blood Transfusion Devices Market Size, by Apheresis System, 2017-2032 (USD Million)
TABLE 284. Latin America Blood Transfusion Devices Market Size, by Blood Bag, 2017-2032 (USD Million)
TABLE 285. Latin America Blood Transfusion Devices Market Size, by Blood Collection Set, 2017-2032 (USD Million)
TABLE 286. Latin America Blood Transfusion Devices Market Size, by Component Separator, 2017-2032 (USD Million)
TABLE 287. Latin America Blood Transfusion Devices Market Size, by Leukocyte Reduction Filter, 2017-2032 (USD Million)
TABLE 288. Latin America Blood Transfusion Devices Market Size, by Transfusion Pump, 2017-2032 (USD Million)
TABLE 289. Latin America Blood Transfusion Devices Market Size, by Component, 2017-2032 (USD Million)
TABLE 290. Latin America Blood Transfusion Devices Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 291. Latin America Blood Transfusion Devices Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 292. Latin America Blood Transfusion Devices Market Size, by White Blood Cells, 2017-2032 (USD Million)
TABLE 293. Latin America Blood Transfusion Devices Market Size, by Mode, 2017-2032 (USD Million)
TABLE 294. Latin America Blood Transfusion Devices Market Size, by Automated, 2017-2032 (USD Million)
TABLE 295. Latin America Blood Transfusion Devices Market Size, by Semi Automated, 2017-2032 (USD Million)
TABLE 296. Latin America Blood Transfusion Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 297. Latin America Blood Transfusion Devices Market Size, by Conventional Flow Control, 2017-2032 (USD Million)
TABLE 298. Latin America Blood Transfusion Devices Market Size, by Electronic Flow Control, 2017-2032 (USD Million)
TABLE 299. Latin America Blood Transfusion Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Latin America Blood Transfusion Devices Market Size, by Apheresis, 2017-2032 (USD Million)
TABLE 301. Latin America Blood Transfusion Devices Market Size, by Blood Collection, 2017-2032 (USD Million)
TABLE 302. Latin America Blood Transfusion Devices Market Size, by Component Separation, 2017-2032 (USD Million)
TABLE 303. Latin America Blood Transfusion Devices Market Size, by Leukocyte Reduction, 2017-2032 (USD Million)
TABLE 304. Latin America Blood Transfusion Devices Market Size, by Transfusion, 2017-2032 (USD Million)
TABLE 305. Latin America Blood Transfusion Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. Latin America Blood Transfusion Devices Market Size, by Blood Banks & Donation Centers, 2017-2032 (USD Million)
TABLE 307. Latin America Blood Transfusion Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 308. Latin America Blood Transfusion Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. Latin America Blood Transfusion Devices Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 310. Latin America Blood Transfusion Devices Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 311. Europe Blood Transfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 312. Europe Blood Transfusion Devices Market Size, by Product, 2017-2032 (USD Million)
TABLE 313. Europe Blood Transfusion Devices Market Size, by Apheresis System, 2017-2032 (USD Million)
TABLE 314. Europe Blood Transfusion Devices Market Size, by Blood Bag, 2017-2032 (USD Million)
TABLE 315. Europe Blood Transfusion Devices Market Size, by Blood Collection Set, 2017-2032 (USD Million)
TABLE 316. Europe Blood Transfusion Devices Market Size, by Component Separator, 2017-2032 (USD Million)
TABLE 317. Europe Blood Transfusion Devices Market Size, by Leukocyte Reduction Filter, 2017-2032 (USD Million)
TABLE 318. Europe Blood Transfusion Devices Market Size, by Transfusion Pump, 2017-2032 (USD Million)
TABLE 319. Europe Blood Transfusion Devices Market Size, by Component, 2017-2032 (USD Million)
TABLE 320. Europe Blood Transfusion Devices Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 321. Europe Blood Transfusion Devices Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 322. Europe Blood Transfusion Devices Market Size, by White Blood Cells, 2017-2032 (USD Million)
TABLE 323. Europe Blood Transfusion Devices Market Size, by Mode, 2017-2032 (USD Million)
TABLE 324. Europe Blood Transfusion Devices Market Size, by Automated, 2017-2032 (USD Million)
TABLE 325. Europe Blood Transfusion Devices Market Size, by Semi Automated, 2017-2032 (USD Million)
TABLE 326. Europe Blood Transfusion Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 327. Europe Blood Transfusion Devices Market Size, by Conventional Flow Control, 2017-2032 (USD Million)
TABLE 328. Europe Blood Transfusion Devices Market Size, by Electronic Flow Control, 2017-2032 (USD Million)
TABLE 329. Europe Blood Transfusion Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. Europe Blood Transfusion Devices Market Size, by Apheresis, 2017-2032 (USD Million)
TABLE 331. Europe Blood Transfusion Devices Market Size, by Blood Collection, 2017-2032 (USD Million)
TABLE 332. Europe Blood Transfusion Devices Market Size, by Component Separation, 2017-2032 (USD Million)
TABLE 333. Europe Blood Transfusion Devices Market Size, by Leukocyte Reduction, 2017-2032 (USD Million)
TABLE 334. Europe Blood Transfusion Devices Market Size, by Transfusion, 2017-2032 (USD Million)
TABLE 335. Europe Blood Transfusion Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Europe Blood Transfusion Devices Market Size, by Blood Banks & Donation Centers, 2017-2032 (USD Million)
TABLE 337. Europe Blood Transfusion Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 338. Europe Blood Transfusion Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 339. Europe Blood Transfusion Devices Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 340. Europe Blood Transfusion Devices Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 341. Middle East Blood Transfusion Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 342. Middle East Blood Transfusion Devices Market Size, by Product, 2017-2032 (USD Million)
TABLE 343. Middle East Blood Transfusion Devices Market Size, by Apheresis System, 2017-2032 (USD Million)
TABLE 344. Middle East Blood Transfusion Devices Market Size, by Blood Bag, 2017-2032 (USD Million)
TABLE 345. Middle East Blood Transfusion Devices Market Size, by Blood Collection Set, 2017-2032 (USD Million)
TABLE 346. Middle East Blood Transfusion Devices Market Size, by Component Separator, 2017-2032 (USD Million)
TABLE 347. Middle East Blood Transfusion Devices Market Size, by Leukocyte Reduction Filter, 2017-2032 (USD Million)
TABLE 348. Middle East Blood Transfusion Devices Market Size, by Transfusion Pump, 2017-2032 (USD Million)
TABLE 349. Middle East Blood Transfusion Devices Market Size, by Component, 2017-2032 (USD Million)
TABLE 350. Middle East Blood Transfusion Devices Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 351. Middle East Blood Transfusion Devices Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 352. Middle East Blood Transfusion Devices Market Size, by White Blood Cells, 2017-2032 (USD Million)
TABLE 353. Middle East Blood Transfusion Devices Market Size, by Mode, 2017-2032 (USD Million)
TABLE 354. Middle East Blood Transfusion Devices Market Size, by Automated, 2017-2032 (USD Million)
TABLE 355. Middle East Blood Transfusion Devices Market Size, by Semi Automated, 2017-2032 (USD Million)
TABLE 356. Middle East Blood Transfusion Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 357. Middle East Blood Transfusion Devices Market Size, by Conventional Flow Control, 2017-2032 (USD Million)
TABLE 358. Middle East Blood Transfusion Devices Market Size, by Electronic Flow Control, 2017-2032 (USD Million)
TABLE 359. Middle East Blood

Companies Mentioned

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Cerus Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • Macopharma SA
  • Nipro Medical Corporation
  • Sarstedt AG & Co. KG
  • Siemens AG
  • SURU INTERNATIONAL PVT. LTD.
  • Terumo Corporation